Convalife Pharmaceuticals Overview
- Year Founded
-
2015
- Status
-
IPO Registration
- Employees
-
67
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
12
Convalife Pharmaceuticals General Information
Description
Researcher and developer of innovative drugs focused on oncology treatments. The company focuses on antibody biopharmaceuticals and small molecule drug in tumor disease field, aiming to provide cancer patients with treatment options.
Contact Information
Website
www.convalife.comCorporate Office
- No. 26, Lane 1000, Zhangheng Road
- Pudong New Area
- Shanghai, 201203
- China
Corporate Office
- No. 26, Lane 1000, Zhangheng Road
- Pudong New Area
- Shanghai, 201203
- China
Convalife Pharmaceuticals Timeline
Convalife Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. IPO | 31-Aug-2025 | Announced | Generating Revenue | |||
| 8. Later Stage VC (Series C2) | 30-Jul-2025 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 19-Jun-2025 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 08-Nov-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 04-Jan-2024 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series B) | 04-Jan-2023 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series A) | 09-Apr-2021 | Completed | Clinical Trials - General | |||
| 2. Later Stage VC | 06-Aug-2020 | $2M | $3.49M | Completed | Clinical Trials - General | |
| 1. Early Stage VC | 22-Dec-2019 | $1.49M | $1.49M | Completed | Clinical Trials - General |
Convalife Pharmaceuticals Patents
Convalife Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026228753-A1 | Pyrimidoindole compound, and composition comprising same and use thereof | Pending | 30-Apr-2025 | ||
| WO-2026228751-A1 | Polysubstituted pyridine derivative, and preparation method therefor and use thereof | Pending | 29-Apr-2025 | ||
| WO-2026228599-A1 | 1,2,3,6-tetrahydropyridine-4-carboxylic acid derivative, and composition and use thereof | Pending | 28-Apr-2025 | ||
| WO-2026218559-A1 | Diphenyl ether derivative, intermediate thereof, and use thereof | Pending | 18-Apr-2025 | ||
| WO-2026219178-A1 | Pharmaceutical composition and use thereof | Pending | 14-Apr-2025 |
Convalife Pharmaceuticals Signals
Convalife Pharmaceuticals Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Optics Valley Financial Holdings Group | Corporation | Minority | ||
| Wuhan High Tech Medical Instrument Park | Corporation | Minority | ||
| Chengrong Investment | Growth/Expansion | Minority | ||
| Veken Holding Group | Corporation | Minority | ||
| Vista Investment | Venture Capital | Minority |
Convalife Pharmaceuticals FAQs
-
When was Convalife Pharmaceuticals founded?
Convalife Pharmaceuticals was founded in 2015.
-
Where is Convalife Pharmaceuticals headquartered?
Convalife Pharmaceuticals is headquartered in Shanghai, China.
-
What is the size of Convalife Pharmaceuticals?
Convalife Pharmaceuticals has 67 total employees.
-
What industry is Convalife Pharmaceuticals in?
Convalife Pharmaceuticals’s primary industry is Drug Delivery.
-
Is Convalife Pharmaceuticals a private or public company?
Convalife Pharmaceuticals is a Private company.
-
What is Convalife Pharmaceuticals’s current revenue?
The current revenue for Convalife Pharmaceuticals is .
-
How much funding has Convalife Pharmaceuticals raised over time?
Convalife Pharmaceuticals has raised $59.8M.
-
Who are Convalife Pharmaceuticals’s investors?
Optics Valley Financial Holdings Group, Wuhan High Tech Medical Instrument Park, Chengrong Investment, Veken Holding Group, and Vista Investment are 5 of 12 investors who have invested in Convalife Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process